|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600126050 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-03 09:31:38 |
|
注册时间: Date of Registration: |
2026-06-03 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于随机森林的老年髋部骨折术后下肢深静脉血栓风险预测模型的构建与验证 |
|
Public title: |
Development and Validation of a Random Forest-Based Risk Prediction Model for Deep Vein Thrombosis Following Hip Fracture Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于随机森林的老年髋部骨折术后下肢深静脉血栓风险预测模型的构建与验证 |
|
Scientific title: |
Development and Validation of a Random Forest-Based Risk Prediction Model for Deep Vein Thrombosis Following Hip Fracture Surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
曾擎天 |
研究负责人: |
曾擎天 |
|
Applicant: |
Qingtian Zeng |
Study leader: |
Qingtian Zeng |
|
申请注册联系人电话: Applicant telephone: |
+86 135 7697 0286 |
研究负责人电话:
Study leader's |
+86 135 7697 0286 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zengqingtian@jxutcm.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
zengqingtian@jxutcm.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国江西省萍乡市安源区楚萍西路10号 |
研究负责人通讯地址: |
中国江西省萍乡市安源区楚萍西路10号 |
|
Applicant address: |
10 Chuping West Road, Anyuan District, Pingxiang, Jiangxi, China |
Study leader's address: |
10 Chuping West Road, Anyuan District, Pingxiang, Jiangxi, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
萍乡市中医院 |
||
|
Applicant's institution: |
Pingxiang Chinese Medicine Hospital |
||
|
研究负责人所在单位: |
萍乡市中医院 |
||
|
Affiliation of the Leader: |
Pingxiang Chinese Medicine Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
萍乡市中医院(伦理)2026(研)第001号-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
萍乡市中医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Pingxiang Traditional Chinese Medicine Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-01-20 00:00:00 | ||
|
伦理委员会联系人: |
易玺 |
||
|
Contact Name of the ethic committee: |
Xi Yi |
||
|
伦理委员会联系地址: |
中国江西省萍乡市安源区楚萍西路10号 |
||
|
Contact Address of the ethic committee: |
10 Chuping West Road, Anyuan District, Pingxiang, Jiangxi, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 799 633 3591 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
萍乡市中医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Pingxiang Chinese Medicine Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国江西省萍乡市安源区楚萍西路10号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
10 Chuping West Road, Anyuan District, Pingxiang, Jiangxi, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
院内筹措资金;江西省2025年度研究生创新专项资金项目YC2025-S701 |
||||||||||||||||||||||
|
Source(s) of funding: |
Institutional Integrated Research Fund;Jiangxi Province 2025 Graduate Students Innovation Fund Project (Project No. YC2025-S701) |
||||||||||||||||||||||
|
研究疾病: |
深静脉血栓 |
||||||||||||||||||||||
|
Target disease: |
Deep Vein Thrombosis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
构建并验证一个基于随机森林与逻辑回归融合算法的老年髋部骨折术后DVT风险预测模型,识别并量化影响老年髋部骨折患者术后发生DVT的关键独立危险因素。 |
||||||||||||||||||||||
|
Objectives of Study: |
Develop and validate a risk prediction model for postoperative DVT in elderly patients with hip fracture, based on an ensemble algorithm combining Random Forest and Logistic Regression, to identify and quantify key independent risk factors. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1、 年龄≥65岁。 2、 经影像学(X线、CT或MRI)确诊为股骨颈骨折、股骨粗隆间骨折或粗隆下骨折,并接受手术治疗(包括外固定、内固定或半髋及全髋关节置换)。 3、 术前及术后一周内完成凝血功能检查及双下肢深静脉彩色多普勒超声检查以明确DVT。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age >= 65 years. 2.Diagnosis of femoral neck fracture, intertrochanteric fracture, or subtrochanteric fracture confirmed by imaging (X-ray, CT or MRI), and having undergone surgical treatment (including external fixation, internal fixation, or hemiarthroplasty/total hip arthroplasty). 3.Completion of bilateral lower limb deep vein color Doppler ultrasound and coagulation function tests within one week before and after surgery to confirm the presence or absence of Deep Vein Thrombosis (DVT). |
||||||||||||||||||||||
|
排除标准: |
1、 合并有严重基础疾病,或在ICU病区的患者; 2、 开放性或合并有血管、神经和内脏损伤的全身性骨折患者; 3、 骨质疏松严重,预后不良的患者; 4、 入院前已确诊DVT或正在接受长期抗凝治疗的患者。 5、 临床资料严重缺失,无法满足建模所需的关键变量。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Patients with severe underlying diseases or those admitted to the Intensive Care Unit. 2.Patients with systemic fractures that are open or combined with vascular, nerve, and visceral injuries. 3.Patients with severe osteoporosis and poor prognosis. 4.Patients diagnosed with Deep Vein Thrombosis prior to admission or undergoing long-term anticoagulant therapy. 5.Patients with severely incomplete clinical data lacking key variables required for model development. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-04-22 00:00:00至 To 2026-10-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-06-05 00:00:00 至 To 2026-10-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2027年10月将通过ResMan(www.medresman.org.cn)方式共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Sharing will be conducted via ResMan (www.medresman.org.cn) in October 2027. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究原始数据保存于萍乡市中医院病案室,统计学研究数据资料由研究负责人保存和使用,所有研究数据和结果按萍乡市中医院数据资料管理要求进行处理和保存。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The original data of this study are stored in the Medical Records Department of Pingxiang Chinese Medicine Hospital. The statistical research data are kept and used by the principal investigator. All research data and results are processed and preserved in accordance with the data management requirements of Pingxiang Chinese Medicine Hospital. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |